CompletedPhase 2/3

Primary Progesterone Therapy for Operable Breast Cancer

India1,000 participantsStarted 1997-10

Plain-language summary

The purpose of this study is to test the effect of primary progesterone on overall and disease free survival in women with operable breast cancer. The study addresses two issues related to breast cancer surgery: * Circulating progesterone at the time of surgery might counteract the detrimental effect of estrogen on survival of women with operable breast cancer. * Events at the time of surgery may have an impact on the natural history of breast cancer

Who can participate

Age range18 Years – 75 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Unilateral operable palpable breast cancer Exclusion Criteria: * Previous history of excision biopsy of the primary tumour * History of other epithelial/mesenchymal malignant tumours except basal cell carcinoma/squamous cell carcinoma (BCC/SCC) of skin

What they're measuring

To test the effect of primary progesterone in operable breast cancer on overall and disease free survival at 5 years

Timeframe: 5 years

Trial details

NCT IDNCT00123669

SponsorTata Memorial Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-05-29

View on ClinicalTrials.gov More Breast Neoplasms trials